Lead Plaintiff Deadline is Approaching - Act Now

AstraZeneca PLC® Class Action

Saleh v. AstraZeneca PLC et al.

NASDAQ: AZN

Class Period : 02/23/2022 - 12/17/2024

Lead Plaintiff Motion Deadline: 2/21/2025

Alleged Misstatements and Omissions
The AstraZeneca class action lawsuit stems from misrepresentations made by the company regarding its operations in China. Key claims include:

  • Exaggerated Financial Performance: AstraZeneca highlighted rising demand and its competitive advantage in China, falsely attributing its success to legitimate factors such as new product approvals and strong demand growth.
  • Misleading Legal Compliance: AstraZeneca made positive statements about its legal compliance and business practices, which were later revealed to be fraudulent.

The truth was uncovered when it was revealed that illegal actions, including a large-scale insurance fraud scheme and the illicit importation of drugs, drove AstraZeneca's financial performance in China. Key company executives, including the President of AstraZeneca's Chinese division, were arrested for their involvement.

Effects on Stock Prices

  • October 30, 2024: AstraZeneca announced that its Chinese president was under investigation by authorities. Following this news, AstraZeneca's ADS price dropped $4.07, or 5.4%, to $71.15 per share.
  • November 5, 2024: A report exposed the scale of the fraud involving dozens of senior executives. The news caused AstraZeneca's stock price to decline by $7.58, or 10.6%, to $63.85 per share.
  • December 18, 2024: An article revealed that AstraZeneca's executives expected a significant revenue hit in China following the arrest of key leaders. This further dropped $2.54 per ADS, or 3.8%, to $64.64 per share.

These revelations resulted in significant financial losses for investors.

Legal Rights for Affected Shareholders
Shareholders who purchased AstraZeneca ADSs during the class period and suffered financial losses may have legal grounds to recover their damages. The lawsuit claims violations of securities laws, alleging AstraZeneca misled investors about its operations and legal standing in China.

By joining this class action, affected investors can:

  • Seek compensation for their financial losses related to AstraZeneca stock.
  • Hold the company accountable for its fraudulent practices.
  • Ensure that greater transparency is maintained for future investors.

If you bought AstraZeneca shares and suffered losses, you may be eligible to participate in the class action lawsuit.

Take Action Today
To protect your legal rights and explore your options, contact experienced attorneys specializing in securities fraud. Acting promptly ensures your claim is filed within the legal deadlines.

Join the AstraZeneca class action today to demand accountability and seek compensation for your losses. Don't wait—take action now to safeguard your rights.

iStock-2148360448

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we defend shareholders like you against deceptive corporate practices. With a proven track record in class action lawsuits, we will work tirelessly to secure the compensation you deserve.  

Here's how we can help:  

  1. Conduct a thorough investigation into your claims.  
  2. Build a strong case to hold AstraZeneca PLC® accountable.  
  3. Pursue maximum compensation for your financial losses.  

You don't have to face this fight alone. Contact DiCello Levitt today for a free, private case evaluation. Together, we'll explore your legal options and assess your potential compensation. Take action now to protect your rights and reclaim what you've lost.  

All victims affected by AstraZeneca PLC® alleged deceptive practices and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

Find Out if You may be a Member
of the Class

AstraZeneca PLC® Class Action

Saleh v. AstraZeneca PLC et al.

NASDAQ: AZN

Class Period : 02/23/2022 - 12/17/2024

Lead Plaintiff Motion Deadline: 2/21/2025

Alleged Misstatements and Omissions
The AstraZeneca class action lawsuit stems from misrepresentations made by the company regarding its operations in China. Key claims include:

  • Exaggerated Financial Performance: AstraZeneca highlighted rising demand and its competitive advantage in China, falsely attributing its success to legitimate factors such as new product approvals and strong demand growth.
  • Misleading Legal Compliance: AstraZeneca made positive statements about its legal compliance and business practices, which were later revealed to be fraudulent.

The truth was uncovered when it was revealed that illegal actions, including a large-scale insurance fraud scheme and the illicit importation of drugs, drove AstraZeneca's financial performance in China. Key company executives, including the President of AstraZeneca's Chinese division, were arrested for their involvement.

Effects on Stock Prices

  • October 30, 2024: AstraZeneca announced that its Chinese president was under investigation by authorities. Following this news, AstraZeneca's ADS price dropped $4.07, or 5.4%, to $71.15 per share.
  • November 5, 2024: A report exposed the scale of the fraud involving dozens of senior executives. The news caused AstraZeneca's stock price to decline by $7.58, or 10.6%, to $63.85 per share.
  • December 18, 2024: An article revealed that AstraZeneca's executives expected a significant revenue hit in China following the arrest of key leaders. This further dropped $2.54 per ADS, or 3.8%, to $64.64 per share.

These revelations resulted in significant financial losses for investors.

Legal Rights for Affected Shareholders
Shareholders who purchased AstraZeneca ADSs during the class period and suffered financial losses may have legal grounds to recover their damages. The lawsuit claims violations of securities laws, alleging AstraZeneca misled investors about its operations and legal standing in China.

By joining this class action, affected investors can:

  • Seek compensation for their financial losses related to AstraZeneca stock.
  • Hold the company accountable for its fraudulent practices.
  • Ensure that greater transparency is maintained for future investors.

If you bought AstraZeneca shares and suffered losses, you may be eligible to participate in the class action lawsuit.

Take Action Today
To protect your legal rights and explore your options, contact experienced attorneys specializing in securities fraud. Acting promptly ensures your claim is filed within the legal deadlines.

Join the AstraZeneca class action today to demand accountability and seek compensation for your losses. Don't wait—take action now to safeguard your rights.

iStock-2148360448

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we defend shareholders like you against deceptive corporate practices. With a proven track record in class action lawsuits, we will work tirelessly to secure the compensation you deserve.  

Here's how we can help:  

  1. Conduct a thorough investigation into your claims.  
  2. Build a strong case to hold AstraZeneca PLC® accountable.  
  3. Pursue maximum compensation for your financial losses.  

You don't have to face this fight alone. Contact DiCello Levitt today for a free, private case evaluation. Together, we'll explore your legal options and assess your potential compensation. Take action now to protect your rights and reclaim what you've lost.  

All victims affected by AstraZeneca PLC® alleged deceptive practices and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

100% Free & Secure Case Evaluations

Answer a few basic questions to get started

We'll ask specific questions to understand the situation, damage risk, and other vital information to help determine the next steps.

Receive a confidential evaluation

A qualified legal team led by a Financial Products Litigation attorney will consider the facts of your case.

AstraZeneca PLC ® Investors may have grounds to pursue legal action and financial recovery of damages.

This website offers general information only and is not legal or investment advice. This advertisement is not associated with any government agency.

www.stockfraudclaim.com is the property of Shield Legal LLC. 5170 Badura Ave Las Vegas, NV 89118

Participating law firm: DiCello Levitt LLP, 10 North Dearborn Street Sixth Floor Chicago, IL 60602. For additional terms, disclaimers, and conditions, please visit https://dicellolevitt.com/privacy-policy/

This website is not part of the Facebook website or Facebook, Inc., and it is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of Facebook, Inc.

ATTORNEY ADVERTISING. This Website does not provide investment, legal, or medical advice. Every case is evaluated on its facts and circumstances. Valuation depends on facts, injuries, jurisdiction, venue, witnesses, parties, and testimony, among other factors. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Stock Fraud Claim does not itself provide legal services. Cases will be referred to third-party attorneys and law firms.  Court costs and case expenses may be the responsibility of the client. Not available in all states. This advertisement is not intended as a testimonial, endorsement, or dramatization and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either expressed or implied. Anyone considering a lawyer should independently investigate the lawyer's credentials and ability, and not rely upon advertisements or self-proclaimed expertise. Only persons age 18 or older have permission to access our Service. Our Service does not address anyone under 13 ("Children").

NO ATTORNEY-CLIENT RELATIONSHIP. Use of this website, including sending or receiving information through it, does not establish an attorney-client relationship, nor is any non-passworded information considered privileged or confidential. No class has been certified.  Until a case is filed and a class is certified, you are not represented by counsel unless you retain one.  You may select counsel of your choice.  An attorney-client relationship with DiCello Levitt is established only by an express written agreement signed by DiCello Levitt to represent you.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

Privacy Policy | Terms and Conditions | CCPA Privacy Notice | Do Not Sell My Info

©2024 Stock Fraud Claim. All Rights Reserved